These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2999261)

  • 21. Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days.
    Rolando L; Schneider WJ; Steinberg S; Low S; Stiles J; Gomez L; Gershon AA; Brown AE
    Infect Control Hosp Epidemiol; 2010 Sep; 31(9):972-4. PubMed ID: 20666603
    [No Abstract]   [Full Text] [Related]  

  • 22. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-linked immunosorbent assay for susceptibility to varicella.
    Shehab Z; Brunell PA
    J Infect Dis; 1983 Sep; 148(3):472-6. PubMed ID: 6311911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific cellular immunity in immunocompetent children with herpes zoster.
    Terada K; Tanaka H; Kawano S; Kataoka N
    Acta Paediatr; 1998 Jun; 87(6):692-4. PubMed ID: 9686665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical reinfection with varicella-zoster virus.
    Gershon AA; Steinberg SP; Gelb L
    J Infect Dis; 1984 Feb; 149(2):137-42. PubMed ID: 6321605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunity to varicella-zoster virus in a normal adult population.
    Ndumbe PM; Macqueen S; Holzel H; Levinsky RJ
    J Med Microbiol; 1985 Aug; 20(1):105-11. PubMed ID: 2991523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
    Sauerbrei A; Wutzler P
    J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
    Sauerbrei A; Wutzler P
    Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization: varicella-zoster vaccine.
    Heim LR
    Cutis; 1979 Feb; 23(2):144, 146-7, 152. PubMed ID: 217569
    [No Abstract]   [Full Text] [Related]  

  • 30. Varicella and herpes zoster: differences in antibody response revealed by the platelet aggregation technique.
    Palosuo T
    Scand J Infect Dis; 1972; 4(2):83-9. PubMed ID: 4341817
    [No Abstract]   [Full Text] [Related]  

  • 31. [Varicella-zoster virus infection and the serologic determination of first-infection immunity].
    Schneweis KE; Krentler C; Wolff MH
    Dtsch Med Wochenschr; 1985 Mar; 110(12):453-7. PubMed ID: 2983965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interpretation of varicella serology in pregnancy].
    von Hintzenstern J; Jahn G
    Geburtshilfe Frauenheilkd; 1988 Dec; 48(12):859-62. PubMed ID: 2853094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response after exposure to varicella zoster virus: characterization of virus-specific antibodies and their corresponding antigens.
    Zweerink HJ; Neff BJ
    Infect Immun; 1981 Jan; 31(1):436-44. PubMed ID: 6260665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of antibodies to varicella zoster virus in healthy adults.
    Schoub BD; Johnson S; McAnerney JM
    S Afr Med J; 1985 Jun; 67(23):929-31. PubMed ID: 2988141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
    Harper DR; Grose C
    J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological responses in varicella and zoster assayed by immunoblotting.
    Harper DR; Kangro HO; Heath RB
    J Med Virol; 1988 Aug; 25(4):387-98. PubMed ID: 2844983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections.
    Sundqvist VA; Linde A; Wahren B
    J Clin Microbiol; 1984 Jul; 20(1):94-8. PubMed ID: 6086711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.
    Brunell PA; Gershon AA; Uduman SA; Steinberg S
    J Infect Dis; 1975 Jul; 132(1):49-54. PubMed ID: 169308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.